Cutaneous complications of hormonal replacement therapy (Q41349408)

29 September 2017

1 reference

title

Cutaneous complications of hormonal replacement therapy (English)

1 reference

29 September 2017

Mor Z

1

1 reference

PubMed ID

9034663

29 September 2017

Caspi E

series ordinal

2

1 reference

29 September 2017

1 January 1997

1 reference

29 September 2017

Clinics in Dermatology

1 reference

29 September 2017

15

1 reference

29 September 2017

1

1 reference

29 September 2017

147-154

1 reference

Menopause and coronary heart disease. The Framingham Study

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Presence of an oestradiol receptor-related protein in the skin: changes during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Skin collagen changes related to age and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

The effect of topical oestradiol on skin collagen of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Skin changes in menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Effect of hormone replacement therapy for menopause on the mechanical properties of skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Dermatologic diseases and problems of women throughout the life cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Age and sex associations of 40 autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Systemic lupus erythematosus induced by ovulation induction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Autoimmune progesterone dermatitis: absence of contact sensitivity to glucocorticoids, oestrogen and 17-alpha-OH-progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

1 reference

7 January 2021

A premenstrual urticarial eruption treated with bilateral oophorectomy and hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Photodermatoses in Lagos

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Porphyria cutanea tarda: pregnancy versus estrogen effect

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Melasma. Etiologic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Hyperpigmentation induced by UVB at the application site of estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Estrogen receptors in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Estrogen receptor in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Absence of estrogen receptors in dysplastic nevi and malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

The influence of female hormones on malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Oestrogen and progesterone receptors in lentigo maligna

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Increased epidermal growth factor receptors in seborrheic keratoses and acrochordons of patients with the dysplastic nevus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Pachydermoperiostosis: study of epidermal growth factor and steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Cutaneous ciliated cyst of the scalp. A case report with immunohistochemical evidence for estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

A risk-benefit appraisal of transdermal estradiol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Transdermal estradiol overall safety profile

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Transdermal oestrogen replacement therapy in a Finnish population

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Allergic contact dermatitis from oestradiol in oestrogen patches

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Allergic contact dermatitis from ethanol in a transdermal estradiol patch

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

An Australian experience of transdermal oestradiol patches in a subtropical climate

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Percutaneous Estrogen Therapy—A Semi - Quantitative Histologic Study of the Abdominal Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

A randomized comparison of nonoral estradiol delivery in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900117-4

7 January 2021

10.1016/S0738-081X(96)00117-4

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9034663